Monsanto Roundup Lawsuit

Tuesday, September 29, 2009

US Cervarix delay deals blow to GlaxoSmithKline




US regulators have delayed their decision on whether to approve GlaxoSmithKline's cervical cancer vaccine Cervarix, writes the Daily Mail.

They add, "The ruling from the powerful US Food and Drug Administration had been expected yesterday but instead the body announced it needed more time to consider the application.

The FDA's renewed caution came just a day after the death of 14-year- old Coventry girl Natalie Morton who had been vaccinated with Cervarix."


FULL STORY HERE

Related links:

Cervarix Tested For Boys!

GlaxoSmithKline challenged safety Cervarix anti-cancer vaccine left girl partially paralysed

4,602 Suspected Adverse Reactions to GSK's Cervarix!

Girls used as Guinea Pigs in HPV Trials Admits GSK

GSK - A Catalogue of Disasters!

Glaxo: "Promote More, Feel Better and Live a Life of Luxury"

Glaxo Goes Head-to-Head on HPV

Teenage Girls Sue Over GSK's Cancer Jab, Cervarix!

GlaxoSmithKline submits final study data to FDA for cervical cancer vaccine

HPV Vaccine Video on Youtube

Concerns over GSK's Cervarix vaccine

UP YOURS GLAXO!

Mindy Merck & Gail Glaxo Dilemma

LOLA'S LAND PROMOTING HPV VACCINE

GlaxoSmithKline's Cervarix. Is Your Daughter Safe?

More debate on GSK's Cervarix

Cervical Cancer, Ofsted & GlaxoSmithKline

Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING
Post a Comment